---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-24-099824"
form_type: "8-K"
ticker: "ELV"
cik: "0001156039"
company_name: "Elevance Health, Inc."
filed_at: "2024-04-18T23:59:59+00:00"
generated_at: "2026-06-03T18:09:21.756857+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# Elevance Health Q1 diluted EPS $9.59 (+15.5%); raises FY2024 adj. EPS guidance to >$37.20

## Summary
- Q1 operating revenue $42.3B (+0.9% YoY); diluted EPS $9.59 (+15.5%); adjusted diluted EPS $10.64 (+12.5%).
- Benefit expense ratio 85.6%, improving 20 bps; operating margin 7.1% vs 6.8% YoY.
- Medical membership 46.2M, down 1.9M YoY due to Medicaid attrition, partially offset by commercial growth.
- Carelon revenue $12.1B (+5%); operating gain $0.8B (+10%).
- FY2024 guidance raised: diluted EPS >$34.05, adjusted >$37.20; strategic partnership with CD&R for primary care.

## SEC filing metadata
- accession: 0001193125-24-099824
- form_type: 8-K
- ticker: ELV
- cik: 0001156039
- company_name: Elevance Health, Inc.
- filed_at: 2024-04-18T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1156039/000119312524099824/0001193125-24-099824-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1156039/000119312524099824/d813732d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-24-099824
- JSON: https://secwatch.observer/filing/0001193125-24-099824.json
- Plain text: https://secwatch.observer/filing/0001193125-24-099824.txt

## Key facts
- Earnings Releases
  Elevance Health, Inc. reported the quarter ended March 31, 2024 results: revenue $42.3 billion, EPS $9.59. Guidance raised.
  - Period: the quarter ended March 31, 2024
  - Revenue: $42.3 billion
  - EPS: $9.59
  - Guidance: raised
  - Result: reported results
  source text: language in such filings. --- EX-99.1 (EX-99.1) --- EX-99.1 Exhibit 99.1 EARNINGS RELEASE ELEVANCE HEALTH REPORTS FIRST QUARTER 2024 RESULTS • 1Q 2024 operating revenue of $42.3 billion, up 0.9% from 1Q 2023 • 1Q 2024 diluted EPS 1 of $9.59, up 15.5% from 1Q 2023 and adjusted diluted EPS 2 of $10.64, up 12.5% • FY 2024 diluted EPS and adjusted diluted EPS
  evidence_url: https://www.sec.gov/Archives/edgar/data/1156039/000119312524099824/0001193125-24-099824-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.